This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Genetic Technologies Ltd (GENE)

NASDAQ: Services

Company Cash Flow
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash Flow From Operating Activities
Net Income (Loss) -8.68M -5.42M 963.32K -7.95M
Operating Gains/Losses 405.49K -5.28M 305.45K -181.71K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 155.27K 182.69K 85.81K 913.26K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets -178.00K -15.17K 0.00 0.00
(Decrease) Increase In Payables 435.89K -214.30K -86.19K -818.33K
(Decrease) Increase In Other Current Liabilities 14.83K 0.00 -33.02K -29.38K
(Increase) Decrease In Other Working Capital 50.23K 194.72K 44.67K -328.91K
Other Non-Cash Items 319.28K 2.18M 558.81K 1.52M
Net Cash From Continuing Operations -6.97M -7.86M 2.39M -3.66M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -6.97M -7.86M 2.39M -3.66M
Sale of Property, Plant & Equipment 1.11K 32.21K 154.66K 4.23K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -49.74K -78.15K -149.28K -329.05K
Acquisitions -117.14K 10.00 0.00 -809.48K
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 549.97K 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -165.77K 504.04K 5.38K -883.42K
Issuance of Debt 0.00 1.02M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 446.78K 11.16M 0.00 859.77K
Repayment of Long-Term Debt -16.47K -1.08M -336.41K -191.57K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -23.94K 0.00 0.00 0.00
Net Cash From Financing Activities 406.38K 11.11M -336.41K 668.20K
Effect of Exchange Rate Changes 72.87K 129.54K -133.80K 30.20K
Net Change in Cash & Cash Equivalents -6.66M 3.89M 1.92M -3.84M
GENE News

GENE Genetic Technologies Ltd

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 1 1 1
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GENE ANALYST REPORT

Brokerage Partners

GENE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs